Kimberly A. Smith

4.6k total citations
56 papers, 2.8k citations indexed

About

Kimberly A. Smith is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Kimberly A. Smith has authored 56 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Surgery, 22 papers in Cardiology and Cardiovascular Medicine and 22 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Kimberly A. Smith's work include Coronary Interventions and Diagnostics (21 papers), Pulmonary Hypertension Research and Treatments (13 papers) and Cardiac Imaging and Diagnostics (11 papers). Kimberly A. Smith is often cited by papers focused on Coronary Interventions and Diagnostics (21 papers), Pulmonary Hypertension Research and Treatments (13 papers) and Cardiac Imaging and Diagnostics (11 papers). Kimberly A. Smith collaborates with scholars based in United States, Japan and China. Kimberly A. Smith's co-authors include Paul T. Schumacker, Gregory B. Waypa, Jason X.‐J. Yuan, Augusto D. Pichard, Ron Waksman, Lowell F. Satler, Kenneth M. Kent, Zhenyi Xue, Rebecca Torguson and William O. Suddath and has published in prestigious journals such as Circulation, PLoS ONE and Circulation Research.

In The Last Decade

Kimberly A. Smith

55 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kimberly A. Smith United States 29 1.3k 1.1k 863 645 451 56 2.8k
Akira Matsunaga Japan 28 1.1k 0.9× 655 0.6× 220 0.3× 452 0.7× 231 0.5× 154 2.5k
Toshiaki Ebina Japan 32 1.0k 0.8× 1.8k 1.6× 402 0.5× 808 1.3× 761 1.7× 197 3.4k
Richard M. Cubbon United Kingdom 32 354 0.3× 1.2k 1.1× 298 0.3× 857 1.3× 118 0.3× 123 3.1k
Shin‐ichiro Miura Japan 26 719 0.6× 1.4k 1.2× 332 0.4× 585 0.9× 351 0.8× 250 2.9k
Toru Miyoshi Japan 37 1.2k 0.9× 2.2k 1.9× 464 0.5× 895 1.4× 735 1.6× 233 4.4k
Nauder Faraday United States 27 653 0.5× 1.5k 1.3× 326 0.4× 356 0.6× 136 0.3× 79 2.8k
Luc Hittinger France 41 559 0.4× 2.9k 2.6× 689 0.8× 1.4k 2.1× 583 1.3× 153 4.5k
Neel R. Sodha United States 24 530 0.4× 713 0.6× 185 0.2× 688 1.1× 91 0.2× 97 2.1k
Jens Lutz Germany 25 551 0.4× 496 0.4× 311 0.4× 570 0.9× 57 0.1× 101 2.5k
Khanh Nguyen United States 26 810 0.6× 592 0.5× 974 1.1× 376 0.6× 72 0.2× 85 2.2k

Countries citing papers authored by Kimberly A. Smith

Since Specialization
Citations

This map shows the geographic impact of Kimberly A. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kimberly A. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kimberly A. Smith more than expected).

Fields of papers citing papers by Kimberly A. Smith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kimberly A. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kimberly A. Smith. The network helps show where Kimberly A. Smith may publish in the future.

Co-authorship network of co-authors of Kimberly A. Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Kimberly A. Smith. A scholar is included among the top collaborators of Kimberly A. Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kimberly A. Smith. Kimberly A. Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Leung, Nelson, Raymond L. Comenzo, Julian D. Gillmore, et al.. (2024). Renal Response Criteria for Clinical Trials in Amyloid Light Chain Amyloidosis. Kidney International Reports. 9(7). 1986–1994. 2 indexed citations
2.
Smith, Kimberly A., Gregory B. Waypa, V. Joseph Dudley, et al.. (2020). Role of Hypoxia-Inducible Factors in Regulating Right Ventricular Function and Remodeling during Chronic Hypoxia–induced Pulmonary Hypertension. American Journal of Respiratory Cell and Molecular Biology. 63(5). 652–664. 33 indexed citations
3.
Waypa, Gregory B., Kimberly A. Smith, & Paul T. Schumacker. (2016). O 2 sensing, mitochondria and ROS signaling: The fog is lifting. Molecular Aspects of Medicine. 47-48. 76–89. 144 indexed citations
4.
Smith, Kimberly A., Guillaume Voiriot, Haiyang Tang, et al.. (2015). Notch Activation of Ca2+ Signaling in the Development of Hypoxic Pulmonary Vasoconstriction and Pulmonary Hypertension. American Journal of Respiratory Cell and Molecular Biology. 53(3). 355–367. 85 indexed citations
5.
Yoo, Hae Young, Eun‐A Ko, Kimberly A. Smith, et al.. (2013). Optimization of Isolated Perfused/Ventilated Mouse Lung to Study Hypoxic Pulmonary Vasoconstriction. Pulmonary Circulation. 3(2). 396–405. 15 indexed citations
6.
Buch, Ashesh N., Aamir Javaid, Daniel Steinberg, et al.. (2008). Outcomes After Sirolimus- and Paclitaxel-Eluting Stent Implantation in Patients With Insulin-Treated Diabetes Mellitus. The American Journal of Cardiology. 101(9). 1253–1258. 12 indexed citations
7.
Roy, Probal, Laurent Bonello, Axel de Labriolle, et al.. (2008). Two-Year Outcome of Patients Treated With Sirolimus- Versus Paclitaxel-Eluting Stents in an Unselected Population With Coronary Artery Disease (from the REWARDS Registry). The American Journal of Cardiology. 102(3). 292–297. 7 indexed citations
8.
Slottow, Tina L. Pinto, Daniel Steinberg, Probal Roy, et al.. (2008). Drug-eluting stents are associated with similar cardiovascular outcomes when compared to bare metal stents in the setting of acute myocardial infarction. Cardiovascular revascularization medicine. 9(1). 24–28. 16 indexed citations
9.
Javaid, Aamir, Nauman Siddiqi, Daniel Steinberg, et al.. (2008). Adjunct Thrombus Aspiration Reduces Mortality in Patients Undergoing Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction With High-Risk Angiographic Characteristics. The American Journal of Cardiology. 101(4). 452–456. 18 indexed citations
10.
Roy, Probal, Rebecca Torguson, Teruo Okabe, et al.. (2007). Comparison between sirolimus‐ and paclitaxel‐eluting stents in complex patient and lesions subsets. Catheterization and Cardiovascular Interventions. 70(2). 167–172. 8 indexed citations
11.
Steinberg, Daniel, Tina L. Pinto Slottow, Ashesh N. Buch, et al.. (2007). Impact of In-Stent Restenosis on Death and Myocardial Infarction. The American Journal of Cardiology. 100(7). 1109–1113. 16 indexed citations
12.
Roy, Probal, Ashesh N. Buch, Aamir Javaid, et al.. (2007). Impact of “Off-Label” Utilization of Drug-Eluting Stents on Clinical Outcomes in Patients Undergoing Percutaneous Coronary Intervention. The American Journal of Cardiology. 101(3). 293–299. 30 indexed citations
13.
Buch, Ashesh N., Suman Singh, Probal Roy, et al.. (2007). Measuring Aspirin Resistance, Clopidogrel Responsiveness, and Postprocedural Markers of Myonecrosis in Patients Undergoing Percutaneous Coronary Intervention. The American Journal of Cardiology. 99(11). 1518–1522. 42 indexed citations
14.
Roy, Probal, Teruo Okabe, Tina L. Pinto Slottow, et al.. (2007). Correlates of Clinical Restenosis Following Intracoronary Implantation of Drug-Eluting Stents. The American Journal of Cardiology. 100(6). 965–969. 30 indexed citations
15.
Smith, Kimberly A., Rebecca Torguson, Teruo Okabe, et al.. (2007). Treatment of drug‐eluting stent restenosis with the same versus different drug‐eluting stent. Catheterization and Cardiovascular Interventions. 70(1). 9–14. 48 indexed citations
16.
Waksman, Ron, Ashesh N. Buch, Rebecca Torguson, et al.. (2007). Long-Term Clinical Outcomes and Thrombosis Rates of Sirolimus-Eluting Versus Paclitaxel-Eluting Stents in an Unselected Population With Coronary Artery Disease (REWARDS Registry). The American Journal of Cardiology. 100(1). 45–51. 25 indexed citations
17.
Steinberg, Daniel, Sundeep Mishra, Aamir Javaid, et al.. (2007). Comparison of Effectiveness of Bare Metal Stents Versus Drug-Eluting Stents in Large (≥3.5 mm) Coronary Arteries. The American Journal of Cardiology. 99(5). 599–602. 44 indexed citations
18.
Kuchulakanti, Pramod K., William W. Chu, Rebecca Torguson, et al.. (2006). Correlates and Long-Term Outcomes of Angiographically Proven Stent Thrombosis With Sirolimus- and Paclitaxel-Eluting Stents. Circulation. 113(8). 1108–1113. 480 indexed citations
19.
Torguson, Rebecca, Manel Sabaté, Regina Deible, et al.. (2006). Intravascular Brachytherapy Versus Drug-Eluting Stents for the Treatment of Patients With Drug-Eluting Stent Restenosis. The American Journal of Cardiology. 98(10). 1340–1344. 53 indexed citations
20.
Smith, Kimberly A., et al.. (1995). Perioperative Perspective of a United Nations Humanitarian Mission. AORN Journal. 62(6). 875–883. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026